Overview

Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to construct a noninvasive approach 68Ga-TTP PET/CT to detect the TROP2 expression of tumor lesions in patients with breast tumors and evaluate the efficacy of ADC drug therapy.
Phase:
NA
Details
Lead Sponsor:
Peking University Cancer Hospital & Institute
Collaborator:
Yunnan Cancer Hospital
Treatments:
Fluorodeoxyglucose F18